StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)

Close on Nov 18, 2026Market cap $121.23MP/E –Yield –

NRX Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

NRX Pharmaceuticals's pe ratio was 813.6× on Jan 31, 2020.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2020Jan 31, 2020813.6×+6.9
2019Dec 31, 2019806.8×–

More NRX Pharmaceuticals figures

See a number that looks wrong?